Company Overview

Medical Marijuana, Inc. is a publicly traded cannabis and hemp-focused company that operates primarily in the nutraceutical, wellness, and cannabinoid consumer products industries. The company is known for developing, marketing, and distributing hemp-derived cannabidiol (CBD) products and related wellness solutions through a portfolio of subsidiaries and affiliated businesses. Its activities span cannabinoid-based dietary supplements, personal care products, functional foods, and cannabis-related intellectual property and branding initiatives. The company has historically positioned itself as an early entrant in the commercial hemp-derived CBD market in the United States, particularly before broader federal legalization of hemp under the 2018 Farm Bill.

The company’s primary revenue drivers have included sales generated through its branded consumer wellness subsidiaries, including Kannaway and HempMeds, along with international direct-selling operations and CBD product distribution. Medical Marijuana, Inc. has also maintained interests in cannabis research partnerships and product development tied to hemp-derived cannabinoids. Founded in 2009, the company emerged during the early expansion of the legal cannabis industry and evolved from a cannabis advocacy and investment-oriented enterprise into a diversified operator focused on hemp-derived consumer products and global cannabinoid market development.

Business Operations

Medical Marijuana, Inc. conducts operations through multiple subsidiaries and branded business units focused on hemp-derived cannabinoid products, direct selling, and international wellness distribution. Its major operating activities historically centered around Kannaway, a direct-selling and network marketing platform for CBD wellness products, and HempMeds, which distributes hemp-based nutraceutical and personal care products. The company has also been involved in sourcing hemp extracts, formulating cannabinoid-based consumer goods, and developing branded wellness solutions targeting health-conscious consumers, athletes, and alternative wellness markets.

The company operates primarily in the United States while also maintaining international distribution channels in parts of Europe, Latin America, and Asia-Pacific markets through affiliate and subsidiary networks. Medical Marijuana, Inc. has promoted proprietary hemp-derived formulations and has participated in cannabis-related scientific and regulatory initiatives. Public disclosures and company materials reference relationships with research institutions and commercial partners associated with cannabinoid development and market expansion. Data regarding the scale and operational performance of certain subsidiaries is limited in publicly available filings, and some operational details are inconclusive based on available public sources.

Strategic Position & Investments

Medical Marijuana, Inc.’s strategic direction has focused on expanding the global acceptance and commercialization of hemp-derived cannabinoids, particularly CBD-based wellness products. The company has historically emphasized international market development, direct-selling expansion, and regulatory engagement tied to cannabis and hemp policy. Growth initiatives have included product diversification, entry into emerging cannabinoid categories, and expansion of consumer education surrounding non-psychoactive hemp derivatives. The company has also sought to position itself within the broader health and wellness sector rather than the recreational cannabis market.

The company has maintained ownership or controlling interests in subsidiaries including Kannaway and HempMeds, which have served as central components of its commercial strategy. Medical Marijuana, Inc. has also referenced investments and participation in cannabinoid science, product formulation technologies, and international hemp commercialization opportunities. Public disclosures indicate ongoing interest in emerging cannabinoid sectors, including non-THC wellness applications and pharmaceutical-adjacent research collaborations. While the company has announced strategic partnerships and expansion efforts over time, the long-term commercial impact of several initiatives remains difficult to independently verify through current public financial disclosures.

Geographic Footprint

Medical Marijuana, Inc. is headquartered in California, United States, and has operated through domestic and international distribution networks focused on hemp-derived wellness products. The company’s core commercial activities have historically been concentrated in the United States, where it markets CBD-based products through direct sales, online channels, and affiliated distributors. It has also developed an international presence through subsidiaries and market-entry initiatives targeting countries with evolving hemp and cannabinoid regulations.

The company has reported business activity and product availability across regions including North America, Europe, Latin America, and parts of Asia-Pacific. International operations have largely centered on direct-selling infrastructure, distributor recruitment, and localized CBD product offerings adapted to regional regulatory environments. Public filings and corporate disclosures indicate varying levels of operational scale across these markets, and complete verification of active market penetration in all referenced jurisdictions is inconclusive based on available public sources.

Leadership & Governance

Medical Marijuana, Inc. has undergone multiple leadership transitions since its founding and has historically been managed by executives with backgrounds in cannabis commercialization, direct selling, and wellness products. The company’s governance structure reflects its status as an over-the-counter publicly traded entity, with strategic emphasis placed on cannabinoid market development, international expansion, and hemp-based consumer product adoption. Public communications and filings have consistently highlighted industry advocacy and early-market positioning as central elements of corporate strategy.

Key executives and leadership figures associated with the company include:

• Blake Schroeder – Chief Executive Officer
• Joseph Dowling – Former Chief Executive Officer
• Stuart Titus – Former Chief Executive Officer and Chairman
• Michelle Sides – Chief Operating Officer of affiliated business operations
• David Tobias – Former Chairman and early company executive

Leadership communications have generally emphasized global CBD market expansion, regulatory engagement, and the commercialization of hemp-derived wellness products. Certain executive and board role changes have varied over time across public disclosures and company announcements.